While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
Researchers have a new hope for preventing severe illness from the bird flu after finding a groundbreaking antibody treatment ...
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...
Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...